Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy

Clinical trial NCT03042312 · TERMINATED

Trial details

NCT number: NCT03042312
Sponsor: Endocyte
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer

Start date: 2017-07-12
Primary completion: 2020-01-15
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.